» Articles » PMID: 28766039

Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical Use in the Clinical Laboratory

Overview
Journal Mycopathologia
Date 2017 Aug 3
PMID 28766039
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Given the complexity of the airway microbiota in the respiratory tract of cystic fibrosis (CF) patients, it seems crucial to compile the most exhaustive and exact list of the microbial communities inhabiting CF airways. The aim of the present study was to compare the bacterial and fungal diversity of sputa from adult CF patients during non-exacerbation period by culture-based and molecular methods, and ultra-deep-sequencing (UDS). Sputum samples from four CF patients were cultured and analysed by DNA extractions followed by terminal restriction fragment length polymorphism analysis through resolution of bacterial ribosomal gene (rDNA) fragments, and cloning plus sequencing of part of fungal rRNA genes. These approaches were compared with UDS method targeting 16S rDNA gene and the internal transcribed spacer (ITS) 2 region of rDNA. A total of 27 bacterial and 18 fungal genera were detected from the four patients. Five (18%) and 3 (16%) genera were detected by culture for bacteria and fungi, respectively, 9 (33%) and 3 (16%) by first generation sequencing (FGS) methods, and 26 (96%) and 18 (100%) by UDS. The mean number of genera detected by UDS per patient was statistically higher than by culture or FGS methods. Patients with severe airway disease as assessed by standard spirometry exhibited a reduced fungal and bacterial diversity. UDS approach evaluates more extensively the diversity of fungal and bacterial flora compared with cultures. However, it currently remains difficult to routinely use UDS mainly because of the lack of standardization, and the current cost of this method.

Citing Articles

Airway Mycobiota-Microbiota During Pulmonary Exacerbation of Cystic Fibrosis Patients: A Culture and Targeted Sequencing Study.

Angebault C, Vandenborght L, Bassinet L, Wizla N, Ferroni A, Dessein R Mycoses. 2025; 68(1):e70024.

PMID: 39816006 PMC: 11736540. DOI: 10.1111/myc.70024.


Metagenomics Applied to the Respiratory Mycobiome in Cystic Fibrosis.

Angebault C, Botterel F Mycopathologia. 2024; 189(5):82.

PMID: 39264513 PMC: 11392981. DOI: 10.1007/s11046-024-00887-6.


Bacteria-Fungi Interactions in Multiple Sclerosis.

Gorostidi-Aicua M, Reparaz I, Otaegui-Chivite A, Garcia K, Romarate L, Alvarez de Arcaya A Microorganisms. 2024; 12(5).

PMID: 38792701 PMC: 11124083. DOI: 10.3390/microorganisms12050872.


Simultaneous Analysis of Bacterial and Fungal Communities in Oral Samples from Intubated Patients in Intensive Care Unit.

Song Y, Kim M, Chung J, Na H Diagnostics (Basel). 2023; 13(10).

PMID: 37238268 PMC: 10217707. DOI: 10.3390/diagnostics13101784.


16S rRNA-Based Microbiota Profiling Assists Conventional Culture Analysis of Airway Samples from Pediatric Cystic Fibrosis Patients.

Kristensen M, de Koff E, Chu M, Groendijk S, Tramper-Stranders G, de Winter-de Groot K Microbiol Spectr. 2023; 11(3):e0405722.

PMID: 37199622 PMC: 10269535. DOI: 10.1128/spectrum.04057-22.


References
1.
Daniels T, Rogers G, Stressmann F, van der Gast C, Bruce K, Jones G . Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis. J Cyst Fibros. 2012; 12(1):22-8. DOI: 10.1016/j.jcf.2012.05.008. View

2.
Armougom F, Bittar F, Stremler N, Rolain J, Robert C, Dubus J . Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing. Eur J Clin Microbiol Infect Dis. 2009; 28(9):1151-4. DOI: 10.1007/s10096-009-0749-x. View

3.
Borman A, Palmer M, Delhaes L, Carrere J, Favennec L, Ranque S . Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. Med Mycol. 2010; 48 Suppl 1:S88-97. DOI: 10.3109/13693786.2010.511287. View

4.
Coburn B, Wang P, Diaz Caballero J, Clark S, Brahma V, Donaldson S . Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep. 2015; 5:10241. PMC: 4431465. DOI: 10.1038/srep10241. View

5.
Blainey P, Milla C, Cornfield D, Quake S . Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med. 2012; 4(153):153ra130. PMC: 3898170. DOI: 10.1126/scitranslmed.3004458. View